Potential biomarkers for predicting outcomes in CABG cardiothoracic surgeries

Related Experiment Video

Updated: May 9, 2026

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
10:03

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty

Published on: January 28, 2020

Isabel Preeshagul1, Rajendra Gharbaran, Kyung Hwa Jeong

  • 1The John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ 07601, USA.

Journal of Cardiothoracic Surgery
|July 23, 2013
PubMed

Insights

This review explores cardiac biomarkers for predicting outcomes in patients after coronary artery bypass graft (CABG) surgery. Identifying reliable biomarkers can improve patient care and recovery predictions.

Area of Science:

  • Cardiology
  • Biomarker Discovery
  • Surgical Outcomes

Background:

  • Coronary artery bypass graft (CABG) patient outcomes vary significantly in recovery, complications, and survival.
  • Current prognostic models rely on patient history, lifestyle, and comorbidities, lacking precise predictive power.
  • Biomarkers offer objective data to forecast clinical course, impacting various medical specialties.

Purpose of the Study:

  • To review and assess existing cardiac biomarkers as predictors of clinical outcomes in post-operative CABG patients.
  • To evaluate the utility of biomarkers in forecasting patient status after cardiothoracic surgery.

Main Methods:

  • Systematic review of studies measuring cardiac biomarkers in pre-operative and post-operative CABG patients.
  • Analysis of data to identify correlations between biomarker levels and clinical outcomes.

Main Results:

  • Cardiac biomarkers show potential for predicting post-CABG recovery time, complication rates, and survival.
  • Specific biomarkers have been identified in recent studies as significant predictors for post-cardiothoracic surgery patients.

Conclusions:

  • Cardiac biomarkers are valuable tools for predicting clinical outcomes in CABG patients.
  • Further research into biomarker applications can enhance patient management and personalized treatment strategies post-surgery.

More Related Videos

Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia07:25

Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia

Published on: September 22, 2020

Surgical Swine Model of Chronic Cardiac Ischemia Treated by Off-Pump Coronary Artery Bypass Graft Surgery09:12

Surgical Swine Model of Chronic Cardiac Ischemia Treated by Off-Pump Coronary Artery Bypass Graft Surgery

Published on: March 27, 2018

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...